APIs pour la recherche et les impuretés

Please enquire for more information about Defluoro paroxetine hydrochloride including the price, delivery time and more detailed product information at the technical inquiry form on this page

Dmab-anabaseine dihydrochloride is an analytical reference standard for HPLC. It has been used as an impurity standard in the production of drugs and drug products. Dmab-anabaseine dihydrochloride is an impurity that can be found in the synthesis of Metabolite. The purity of this compound is 99% with a CAS number of 154149-38-9. Dmab-anabaseine dihydrochloride is natural or synthetic and it does not have any pharmacopoeia listings. Custom synthesis and research and development are some other uses for this product.

N-Propyl-1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenyl-2-propenamide is a drug that belongs to the group of beta blockers. It inhibits the action of catecholamines on β receptors, which in turn reduces cardiac output, heart rate and myocardial oxygen consumption. N-Propyl-1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenyl-2-propenamide has been used in experimental studies to investigate its effects on metabolism.

Fenticonazole sulfone nitric acid salt is an analog of dabigatran, which is a protein kinase inhibitor that has shown potential in the treatment of cancer. It induces apoptosis in human cancer cells and inhibits the activity of various kinases involved in tumor growth and proliferation. Fenticonazole sulfone nitric acid salt has been studied extensively for its anticancer properties, showing promising results in Chinese hamster ovary cells and urine samples from cancer patients. This drug also exhibits inhibitory effects on protein kinases that are involved in the regulation of cell cycle progression, angiogenesis, and metastasis. Overall, Fenticonazole sulfone nitric acid salt holds great promise as a potential anticancer agent.

Please enquire for more information about N,N-Bis(2-chloroethyl)-4-methoxybenzenesulfonamide including the price, delivery time and more detailed product information at the technical inquiry form on this page

2,2',3,4,4',5-Hexachlorobiphenyl is a potent inhibitor of cancer cell growth and has been shown to induce apoptosis in Chinese hamster ovary cells. This compound also inhibits the activity of kinase inhibitors such as chloroquine and artesunate. It has been found in human urine samples and may be involved in the development of cancer. 2,2',3,4,4',5-Hexachlorobiphenyl has been identified as an analog of tumor-promoting compounds and may have potential as an anticancer agent. Further research is needed to fully understand its mechanism of action and potential therapeutic applications.

6,7-Dehydrohyoscyamine (6,7DHHA) is a synthetic alkaloid that is produced by the dehydration of hyoscyamine. It has been shown to be an effective anti-inflammatory agent in both in vitro and in vivo experiments. 6,7DHHA also has a skeleton that is similar to the neurotransmitter acetylcholine, which may account for its effectiveness as an anti-spasmodic drug. This compound has been shown to inhibit the transfer of nerve impulses across synapses by blocking presynaptic acetylcholine receptors. It does this by binding with high affinity to these receptors and preventing them from being activated. 6,7DHHA binds noncompetitively to the receptor site on the acetylcholine receptor and can cross the blood-brain barrier because it is lipid soluble. The biosynthesis of 6,7DHHA starts with two molecules of L-phenylalanine condensed together with one molecule of L-

2-(4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)piperazin-1-yl)ethyl undecanoate is an analytical standard used as a reference compound in the drug development process. It is also used as a pharmacopoeia standard and a custom synthesis. 2-(4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)piperazin-1-yl)ethyl undecanoate is synthesized from natural or synthetic sources. This product has been shown to have an impurity level of less than 1%. 2-(4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)piperazin-1-yl)ethyl undecanoate is not known to be metabolized by the human body and does not produce any metabolites.

Please enquire for more information about N-Acetyl-9-(acetylamino)-9-deoxyneuraminic acid including the price, delivery time and more detailed product information at the technical inquiry form on this page

Polyethylene glycol monoisotridecyl ether (PEG-DTAE) is a polymer that can be used as an antimicrobial agent. It is active against Gram-positive bacteria but not against Gram-negative bacteria. PEG-DTAE has anti-angiogenic effects, which may be due to its ability to inhibit the growth of new blood vessels and thereby prevent the spread of infection. In vitro assays have shown that PEG-DTAE can induce cell lysis and hemolysis in test samples. PEG-DTAE has been shown to have hemolytic activity in vivo in rats, with histology sections showing inflammation and necrosis in the spleen and liver. This polymer also causes symptoms such as fever, chills, rigors, and hypotension in patients with chronic renal failure who are undergoing dialysis.

Despropylrotigotine is a dopamine agonist that is used to treat Parkinson's disease. It is structurally related to rotigotine, which is an active metabolite of the drug. Despropylrotigotine has a long half-life and high potency, making it suitable for once-daily dosing. It has been shown to be well tolerated and effective in clinical trials for the treatment of Parkinson's disease. The pharmacokinetic profile of this drug is similar to that of other drugs in the same class, with despropylrotigotine being able to cross the blood-brain barrier and bind to dopamine receptors in the brain, thereby increasing dopamine levels in Parkinson's patients.